Anticancer agent 284
Anticancer agent 284 exhibits cytotoxicity against osteosarcoma cell line (Hos), non-small cell lung cancer cell line (A549), and colon cancer cell line (HCT-116). Anticancer agent 284 can impact the pRIPK3 kinase concentration in the A549 (2.97 pg/mL). Anticancer agent 284 can be used for the study of cancer.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Formule: C26H25N5O3S
- Masse moléculaire:487.57
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
Activité biologique
Anticancer agent 284 (Compound 4) cytotoxic against all the tested cell lines, with an IC50 activity order of HCT-116 (7.3 µM) > A549 (20.4 µM) > Hos (39.9 µM)[1].
Anticancer agent 284 slightly inhibis pRIPK3 in A549 cells (2.97 pg/mL)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:A549 human lung cancer cells
-
Concentration:20.4 μM (treat with the IC50 concentration of the active compound)
-
Incubation Time:24 h
-
Result:Impacted the pRIPK3 kinase concentration in the A549 (2.97 pg/mL).
Chemical Information
-
Masse moléculaire 487.57
-
Formule C26H25N5O3S
-
SMILES
CC1=CC=C(C=C1)S(=O)(N/N=C(C2=CC=C(C=C2)N/C=C3C(N(N=C/3C)C4=CC=CC=C4)=O)\C)=O
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Anticancer agent 284 Related Classifications
HY-178937 Related Classifications
Powered by Bioz